JPY 1492.0
(2.26%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 1.7 Billion JPY | 25.26% |
2022 | 1.35 Billion JPY | 12.92% |
2021 | 1.2 Billion JPY | 20.05% |
2020 | 1 Billion JPY | 37.15% |
2019 | 730.03 Million JPY | 16.25% |
2018 | 628 Million JPY | -3.13% |
2017 | 648.27 Million JPY | 16.64% |
2016 | 555.77 Million JPY | 25.79% |
2015 | 441.84 Million JPY | 17.41% |
2014 | 376.31 Million JPY | 24.09% |
2013 | 303.24 Million JPY | -2.97% |
2012 | 312.52 Million JPY | 24.76% |
2011 | 250.49 Million JPY | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | 315 Million JPY | -40.5% |
2023 FY | 1.7 Billion JPY | 25.26% |
2023 Q3 | 404.68 Million JPY | 6.04% |
2023 Q1 | 384.45 Million JPY | -26.54% |
2023 Q2 | 381.62 Million JPY | -0.74% |
2023 Q4 | 529.41 Million JPY | 30.82% |
2022 Q4 | 523.31 Million JPY | 61.45% |
2022 FY | 1.35 Billion JPY | 12.92% |
2022 Q3 | 324.14 Million JPY | 27.89% |
2022 Q2 | 253.44 Million JPY | -1.16% |
2022 Q1 | 256.41 Million JPY | -38.58% |
2021 FY | 1.2 Billion JPY | 20.05% |
2021 Q2 | 299.58 Million JPY | 4.64% |
2021 Q4 | 417.5 Million JPY | 110.2% |
2021 Q1 | 286.29 Million JPY | -18.8% |
2021 Q3 | 198.62 Million JPY | -33.7% |
2020 Q1 | 176.57 Million JPY | -43.94% |
2020 Q2 | 176.61 Million JPY | 0.02% |
2020 FY | 1 Billion JPY | 37.15% |
2020 Q3 | 295.43 Million JPY | 67.28% |
2020 Q4 | 352.59 Million JPY | 19.35% |
2019 Q1 | 159.33 Million JPY | -49.51% |
2019 FY | 730.03 Million JPY | 16.25% |
2019 Q2 | 155.14 Million JPY | -2.63% |
2019 Q4 | 314.94 Million JPY | 213.01% |
2019 Q3 | 100.61 Million JPY | -35.14% |
2018 Q4 | 315.57 Million JPY | 226.31% |
2018 Q2 | 99.99 Million JPY | -13.6% |
2018 Q1 | 115.72 Million JPY | -59.2% |
2018 FY | 628 Million JPY | -3.13% |
2018 Q3 | 96.71 Million JPY | -3.28% |
2017 Q3 | 135.75 Million JPY | 46.36% |
2017 FY | 648.27 Million JPY | 16.64% |
2017 Q1 | 136.13 Million JPY | -31.39% |
2017 Q4 | 283.62 Million JPY | 108.92% |
2017 Q2 | 92.75 Million JPY | -31.87% |
2016 Q4 | 198.41 Million JPY | 150.26% |
2016 FY | 555.77 Million JPY | 25.79% |
2016 Q3 | 79.28 Million JPY | -51.69% |
2016 Q2 | 164.12 Million JPY | 44.04% |
2016 Q1 | 113.95 Million JPY | -51.05% |
2015 Q2 | 109.78 Million JPY | 63.76% |
2015 Q4 | 232.78 Million JPY | 621.96% |
2015 Q3 | 32.24 Million JPY | -70.63% |
2015 FY | 441.84 Million JPY | 17.41% |
2015 Q1 | 67.03 Million JPY | -44.58% |
2014 FY | 376.31 Million JPY | 24.09% |
2014 Q4 | 120.95 Million JPY | 53.64% |
2014 Q3 | 78.72 Million JPY | -37.15% |
2014 Q2 | 125.25 Million JPY | 143.8% |
2014 Q1 | 51.37 Million JPY | -72.14% |
2013 Q1 | 24.93 Million JPY | -78.63% |
2013 Q3 | 62.12 Million JPY | 95.48% |
2013 Q4 | 184.4 Million JPY | 196.82% |
2013 FY | 303.24 Million JPY | -2.97% |
2013 Q2 | 31.78 Million JPY | 27.47% |
2012 FY | 312.52 Million JPY | 24.76% |
2012 Q2 | 74 Million JPY | 0.0% |
2012 Q3 | 48 Million JPY | -35.14% |
2012 Q4 | 116.66 Million JPY | 143.06% |
2011 FY | 250.49 Million JPY | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Kitanotatsujin Corporation | 1.44 Billion JPY | -17.323% |
Euglena Co., Ltd. | -2.49 Billion JPY | 168.034% |
Axas Holdings Co.,Ltd. | 14.58 Million JPY | -11558.609% |
C.I. Medical Co.,Ltd. | 2.98 Billion JPY | 43.119% |
Kao Corporation | 60.03 Billion JPY | 97.168% |
Niitaka Co., Ltd. | 1.47 Billion JPY | -15.177% |
Rohto Pharmaceutical Co.,Ltd. | 40.04 Billion JPY | 95.755% |
Shiseido Company, Limited | 28.13 Billion JPY | 93.957% |
Lion Corporation | 20.13 Billion JPY | 91.555% |
Mandom Corporation | 2.02 Billion JPY | 15.833% |
Ivy Cosmetics Corporation | 187.06 Million JPY | -808.854% |
Milbon Co., Ltd. | 5.52 Billion JPY | 69.229% |
Nippon Shikizai, Inc. | 441.74 Million JPY | -284.881% |
Fancl Corporation | 12.57 Billion JPY | 86.475% |
KOSÉ Corporation | 16.27 Billion JPY | 89.553% |
Cota Co., Ltd. | 1.92 Billion JPY | 11.537% |
HABA Laboratories,Inc. | -187.76 Million JPY | 1005.461% |
C'bon Cosmetics Co.,Ltd. | 29.4 Million JPY | -5682.908% |
Pola Orbis Holdings Inc. | 16.08 Billion JPY | 89.427% |
Noevir Holdings Co., Ltd. | 11.02 Billion JPY | 84.578% |
Adjuvant Holdings Co.,Ltd. | -1.42 Million JPY | 119410.526% |
Almado, Inc. | 960.53 Million JPY | -77.003% |
I-ne CO., LTD. | 4.37 Billion JPY | 61.174% |
Premier Anti-Aging Co., Ltd. | 139 Million JPY | -1123.147% |
Liberta Co.,Ltd. | 172.52 Million JPY | -885.466% |
AXXZIA Inc. | 918.34 Million JPY | -85.135% |
S.T. Corporation | 1.34 Billion JPY | -26.69% |
Kobayashi Pharmaceutical Co., Ltd. | 25.78 Billion JPY | 93.405% |
Earth Corporation | 6.37 Billion JPY | 73.31% |
Sagami Rubber Industries Co., Ltd. | 436.44 Million JPY | -289.551% |
Asahi Eito Holdings Co.,Ltd. | -470.27 Million JPY | 461.528% |
Ya-Man Ltd. | 416.27 Million JPY | -308.422% |
MTG Co., Ltd. | 3.59 Billion JPY | 52.734% |
TRANSACTION CO.,Ltd. | 5.23 Billion JPY | 67.512% |
SHOBIDO Corporation | 869.32 Million JPY | -95.575% |
Artnature Inc. | 2.65 Billion JPY | 35.987% |
Pigeon Corporation | 10.72 Billion JPY | 84.151% |
Unicharm Corporation | 127.97 Billion JPY | 98.671% |
Paltac Corporation | 29.04 Billion JPY | 94.147% |
CB GROUP MANAGEMENT Co., Ltd. | 2.76 Billion JPY | 38.444% |